[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623272":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":24,"locations":30,"responsibleParty":60,"collaborators":62,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":70,"sex":76,"minAge":77,"maxAge":10,"enrollmentInfo":78,"targetDuration":10,"studyType":81,"phases":10,"briefSummary":82,"conditions":83,"keywords":87,"overallStatus":89,"whyStopped":10,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Hôpital NOVO","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"Patients with GCA, spondylarthritis and\u002For polymyalgia rheumatica",null,[12],"Other: Description of population",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"Description of population","Description of population in the aim of identify demographic or phenotypic factors different between experimental and control populations.",[9],[19,22],{"name":20,"affiliation":5,"role":21},"Omar AL TABAA","PRINCIPAL_INVESTIGATOR",{"name":23,"affiliation":5,"role":21},"Auriane CHADELAT",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Mathilde WLODARCZYK","CONTACT","0033130754650","mathilde.wlodarczyk@ght-novo.fr",[31,47],{"facility":32,"status":10,"city":33,"state":10,"zip":10,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"CRI (Rheumatism and Inflammatory Club)","Paris","France","FR",{"type":37,"coordinates":38},"Point",[39,40],2.3488,48.85341,{"lat":40,"lon":39},[43],{"name":44,"role":27,"phone":45,"phoneExt":10,"email":46},"Raphaele SEROR","0033145213759","raphaele.seror@aphp.fr",{"facility":48,"status":10,"city":49,"state":10,"zip":10,"country":34,"countryCode":35,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"GEFA (French Group for the study of large vessel Arteritis)","Toulouse",{"type":37,"coordinates":51},[52,53],1.44367,43.60426,{"lat":53,"lon":52},[56],{"name":57,"role":27,"phone":58,"phoneExt":10,"email":59},"Laurent SAILLER","0033561779678","sailler.l@chu-toulouse.fr",{"type":61,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[63,66],{"name":64,"class":65},"GEFA","UNKNOWN",{"name":67,"class":65},"CRI","100623272","study-of-the-association-between-sacroiliitisaxial-spondylarthritis-and-giant-cell-arteritis-polymyalgia-rheumatica-100623272",false,"NCT07394478","Study of the Association Between Sacroiliitis\u002FAxial Spondylarthritis and Giant Cell Arteritis\u002F Polymyalgia Rheumatica","Study of the Association Between Sacroiliitis\u002FAxial Spondylarthritis and Giant Cell Arteritis\u002F Polymyalgia Rheumatica: A Case-control Observational Study","SAGE PPR","Inclusion Criteria:\n\n* Experimental group: Adult patient with spondylitis associated with GCA or PMR Control group: Adult patient with GCA or PMR\n\nExclusion Criteria:\n\n* Refusal to participate\n* Positive anti CCP","ALL","18 Years",{"count":79,"type":80},10,"ESTIMATED","OBSERVATIONAL","The purpose of the study is to recruit as many patients as possible presenting with sacroiliitis or authentic axial spondylarthritis and giant cell arteritis. The investigators will also be interested in the association of spondylarthritis and polymyalgia rheumatica given the continuum between these two pathologies. The aim is to investigate whether there is an association between giant cell arteritis and spondylarthritis or polymyalgia rheumatica and spondylarthritis.",[84,85,86],"Giant Cell Arteritis (GCA)","Spondylarthritis","Polymyalgia Rheumatica",[84,85,88],"Polymyalgia rheumatica","NOT_YET_RECRUITING","2026-02-03",{"date":92,"type":93},"2026-02-06","ACTUAL",{"date":95,"type":80},"2026-02-01",{"date":97,"type":80},"2026-06-30",{"name":5,"class":6},2]